Statistics for Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial
Total visits
| views | |
|---|---|
| Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial | 2 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:f4c672e4-52de-4757-a440-e392f5eb6cb9 | 7 |
| java.util.UUID:6f83364c-5a03-4aee-9189-4ee27593fa60 | 3 |
| Rossing2021Efficacy-CCBYNC.pdf | 1 |
| java.util.UUID:a6aad770-0d4d-4662-adc9-c6bd83152501 | 1 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Indianapolis | 2 |